Researchers pooled data from five previously conducted studies to assess whether time-restricted eating (TRE) window duration influenced weight loss and cardiometabolic markers. The pooled analysis is published in the journal Nutrition & Diabetes. The trials lasted between 3 and 6 months. Participants used a mobile app to track intake with timestamped meal photos and descriptions. The analysis examined differences by assigned eating-window durations and by the eating windows participants actually achieved.
A total of 124 participants were included in the pooled dataset. Ninety-five participants were assigned to TRE interventions and 29 served as controls. Assigned eating-window groups were 8 hours (n = 11), 10 hours (n = 59), and 12 hours (n = 25). Before the trials, participants typically ate over at least 14 hours per day and, during the trials, shortened their daily eating windows by about 4 hours on average.
Control participants either continued their usual eating habits or received brief nutritional counseling and written healthy-eating guidance rather than time-restricted protocols.
Across TRE groups, mean weight loss during the study period was 4.8 pounds. Participants assigned to the 8-hour eating window lost approximately 3.7 pounds more on average than those in the 12-hour group and lost significantly more weight than the control group.
In unadjusted comparisons, the difference between the 8- and 10-hour groups did not reach statistical significance. When researchers examined the actual eating-window durations achieved, shorter windows were associated with greater weight loss; however, this relationship weakened after adjustment for age, sex, and BMI.
The pooled analysis measured multiple cardiometabolic outcomes, including fasting glucose, triglycerides, HDL cholesterol, and calculated LDL cholesterol in most trials. Overall, investigators did not find consistent associations between eating-window duration and improvements in fasting glucose, HDL or LDL cholesterol, or triglycerides.
The single notable cardiometabolic finding was that participants in the 10-hour group had a greater reduction in systolic blood pressure than those in the 12-hour group. Beyond that comparison, eating-window duration was not consistently linked to blood pressure, blood sugar, or cholesterol changes in this pooled dataset.
The authors note several important limitations that affect interpretation of the results. These include:
These constraints limit causal inference about whether eating-window duration per se drives the observed weight differences or cardiometabolic outcomes.
Cheng-Han Chen, MD, an interventional cardiologist not involved in the research, highlighted that the small sample size, differences among trials, and short follow-up likely explain the limited cardiometabolic findings and called for larger, longer studies. Chen emphasized that the field is still in early stages of understanding potential health effects of TRE.
Mir Ali, MD, a bariatric surgeon and bariatric medicine specialist, noted that although the 8-hour group lost more weight than the 12-hour group, the modest magnitude of the difference and small sample size mean results are not conclusive. He observed considerable individual variability in TRE effectiveness and suggested a larger sample with more substantial weight change may be needed to detect consistent cardiometabolic benefits.
Both experts advised caution for certain patient groups. The study authors and commentators recommended that people with type 1 diabetes, hypoglycemia, a history of eating disorders, and those who are pregnant or trying to conceive consult healthcare professionals before attempting TRE. Mir Ali additionally cautioned that conditions such as diabetes may make TRE less feasible or contraindicated for some individuals.
The pooled analysis suggests an 8-hour eating window may produce greater short-term weight loss than longer windows or usual eating patterns, but evidence for improvements in blood pressure and other cardiometabolic markers is inconsistent in this dataset. Given the methodological limitations—small sample sizes, lack of calorie data, trial heterogeneity, and short duration—larger, randomized, longer-term studies are needed to determine who benefits from TRE, to establish whether timing confers metabolic advantages independent of calorie reduction, and to clarify safety and feasibility across clinical populations.
Clinicians and patients should weigh potential benefits for weight loss against individual health conditions and consult healthcare providers before initiating TRE protocols, particularly for people with diabetes, hypoglycemia, pregnancy considerations, or histories of disordered eating.